David A Douglas

Fibroblast growth factor 17 is over‐expressed in human prostate cancer

C. Robson, H. Leung, R. Heer, 2004, The Journal of pathology.

Current drug therapy for prostate cancer: an overview.

B. Birch, B. Lwaleed, A. Stewart, 2005, Current medicinal chemistry. Anti-cancer agents.

Epigenetic inactivation of the human sprouty2 (hSPRY2) homologue in prostate cancer

C. Robson, V. Gnanapragasam, H. Leung, 2005, Oncogene.

Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer

C. Robson, H. Leung, M. Mathers, 2005, British Journal of Cancer.

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle‐invasive transitional cell carcinoma of the bladder

T. Powles, J. Chester, T. Pwint, 2012, Cancer.